HomeStockRegeneron Pharma Earnings, Income Beat in This autumn By

Regeneron Pharma Earnings, Income Beat in This autumn By

© Reuters. Regeneron Pharma Earnings, Income Beat in This autumn – Regeneron Pharma (NASDAQ:) reported on Friday fourth quarter that beat analysts’ forecasts and income that topped expectations.

Regeneron Pharma introduced earnings per share of $23.72 on income of $4.95B. Analysts polled by anticipated EPS of $20.06 on income of $4.5B.

Regeneron Pharma shares are down 1.71% from the start of the yr, nonetheless down 9.60% from its 52 week excessive of $686.62 set on September 3, 2021. They’re outperforming the S&P 500 which is down 6.06% from the beginning of the yr.

Regeneron Pharma follows different main Healthcare sector earnings this month

Regeneron Pharma’s report follows an earnings beat by UnitedHealth on January 19, who reported EPS of $4.48 on income of $73.74B, in comparison with forecasts EPS of $4.3 on income of $72.98B.

J&J had beat expectations on January 25 with fourth quarter EPS of $2.13 on income of $24.8B, in comparison with forecast for EPS of $2.12 on income of $25.28B.

Keep up-to-date on the entire upcoming earnings reviews by visiting’s earnings calendar

Disclaimer: Fusion Media wish to remind you that the information contained on this web site just isn’t essentially real-time nor correct. All CFDs (shares, indexes, futures) and Foreign exchange costs should not offered by exchanges however moderately by market makers, and so costs will not be correct and will differ from the precise market value, which means costs are indicative and never applicable for buying and selling functions. Subsequently Fusion Media doesn`t bear any duty for any buying and selling losses you would possibly incur on account of utilizing this information.

Fusion Media or anybody concerned with Fusion Media won’t settle for any legal responsibility for loss or harm on account of reliance on the knowledge together with information, quotes, charts and purchase/promote indicators contained inside this web site. Please be totally knowledgeable concerning the dangers and prices related to buying and selling the monetary markets, it is without doubt one of the riskiest funding kinds attainable.



Please enter your comment!
Please enter your name here

Most Popular

Recent Comments